Compounds > selegiline
Page last updated: 2024-08-23

selegiline and chitosan

selegiline has been researched along with chitosan in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hallan, SS; Mehra, NK; Mishra, N; Prakash, A; Rashid, M; Singh, D1
Rukmangathen, R; Yalavarthi, PR; Yallamalli, IM1
Bajaj, A; Gaud, R; Sridhar, V; Wairkar, S1

Other Studies

3 other study(ies) available for selegiline and chitosan

ArticleYear
Pharmacological evaluation of nasal delivery of selegiline hydrochloride-loaded thiolated chitosan nanoparticles for the treatment of depression.
    Artificial cells, nanomedicine, and biotechnology, 2016, Volume: 44, Issue:3

    Topics: Administration, Intranasal; Animals; Antidepressive Agents; Chitosan; Depression; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Nanoparticles; Rats; Rats, Wistar; Selegiline

2016
Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease.
    Current drug discovery technologies, 2019, Volume: 16, Issue:4

    Topics: Administration, Intranasal; Animals; Antiparkinson Agents; Brain; Catalase; Catalepsy; Chitosan; Chlorpromazine; Female; Glutathione; Male; Nanoparticles; Nitrites; Parkinson Disease; Rats, Wistar; Selegiline; Thiobarbituric Acid Reactive Substances

2019
Pharmacokinetics and pharmacodynamics of intranasally administered selegiline nanoparticles with improved brain delivery in Parkinson's disease.
    Nanomedicine : nanotechnology, biology, and medicine, 2018, Volume: 14, Issue:8

    Topics: Administration, Intranasal; Animals; Antiparkinson Agents; Behavior, Animal; Biological Availability; Brain; Chitosan; Disease Models, Animal; Drug Carriers; Drug Liberation; Male; Nanoparticles; Parkinson Disease; Rats; Rats, Sprague-Dawley; Selegiline; Tissue Distribution

2018